Our Health Care Litigation Team discusses a District of Massachusetts case holding that allows the government to switch liability theories in its False Claims Act lawsuit against Regeneron Pharmaceuticals....more
8/11/2025
/ Anti-Kickback Statute ,
Department of Justice (DOJ) ,
Discovery ,
False Claims Act (FCA) ,
Healthcare Fraud ,
Litigation Strategies ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Regeneron ,
Summary Judgment
The Second Circuit has made the government’s formerly straightforward task of assigning vicarious liability to a corporate principal under the Foreign Corrupt Practices Act considerably harder. Our White Collar, Government &...more
Alston & Bird’s Coronavirus Flash provides updates on policy and regulatory actions under consideration across many important industries being monitored by our teams. Links to key government and legal resources are provided...more